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1. Introduction 
Marine algae contain large amounts of polysaccharides, notably cell wall structural, but also 
mycopolysaccharides and storage polysaccharides (Kumar et al. 2008b; Murata and 
Nakazoe 2001). Polysaccharides are polymers of simple sugars (monosaccharides) linked 
together by glycosidic bonds, and they have numerous commercial applications in products 
such as stabilisers, thickeners, emulsifiers, food, feed, beverages etc. (McHugh 1987; Tseng 
2001; Bixler and Porse, 2010). The total polysaccharide concentrations in the seaweed species 
of interest range from 4-76 % of the dry weight (Table 1). The highest contents are found in 
species such as Ascophyllum, Porphyra and Palmaria, however, green seaweed species such as 
Ulva also have a high content, up to 65 % of dry weight. 
Seaweeds are low in calories from a nutritional perspective. The lipid content is low and 
even though the carbohydrate content is high, most of this is dietary fibres and not taken up 
by the human body. However, dietary fibres are good for human health as they make an 
excellent intestinal environment (Holt and Kraan, 2011). 
The cell-wall polysaccharides mainly consist of cellulose and hemicelluloses, neutral 
polysaccharides, and they are thought to physically support the thallus in water. The 
building blocks needed to support the thalli of seaweed in water are less rigid/strong 
compared to terrestial plants and trees. The cellulose and hemicellulose content of the 
seaweed species of interest in this review is 2-10 % and 9 % dry weight respectively. Lignin 
is only found in Ulva sp. at concentrations of 3 % dry weight (Table 2).  
The cell wall and storage polysaccharides are species-specific and examples of 
concentrations are given in Table 3. Green algae contain sulphuric acid polysaccharides, 
sulphated galactans and xylans, brown algae alginic acid, fucoidan (sulphated fucose), 
laminarin (β-1, 3 glucan) and sargassan and red algae agars, carrageenans, xylans, floridean 
starch (amylopectin like glucan), water-soluble sulphated galactan , as well as porphyran as  
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Table 1. Content of total polysaccharides (% of dry weight) and structural and dietary fibres (% of dry 
weight) in seaweed species of interest in North-west Europe.  
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Class Genus  Uses 
Chlorophyta   
 Monostroma  edible, human food 
 Enteromorpha edible, human food 
Phaeophyta   
 Laminaria alginates, edible, human food 
 Undaria edible, human food 
 Cladosiphon edible, human food 
Rhodophyta   
 Asparagopsis medical applications 
 Gelidiella agar, food and medical 
 Gelidiopsis agar, food and medical 
 Gelidium agar, food and medical 
 Gracilaria agar, food and medical 
 Pterocladia  agar, food and medical 
 Chondrus  carrageenan, human food 
 Eucheuma  carrageenan, human food 
 Kappaphycus  carrageenan, human food 
 Gigartina carrageenan, human food 
 Hypnea carrageenan, human food 
 Iridaea  carrageenan, human food 
 Palmaria  human and animal feed 
 Porphyra human food 
Table 2. Most common genera and uses of seaweeds produced in aquaculture. 
 
Product Global 
Production 
Retail 
Price 
Approximate Gross 
Market Value 
Amount Used 
   (ton/year) (US$/kg) (US$million/year) Food (%) Pharmacy(%) 
Agars   9,600 18 173 80 ca 15 
Alginates 26,500 12 318 30 5 
Carrageenans 50,000 10.5 525 80 10 
Table 3. Phycocolloids and their global production, retail price, gross value and percentage used in 
food and pharmacy(Data; McHugh, 2003; Bixler and Porse, 2010) 
mucopolysaccharides located in the intercellular spaces (Table 3; Kumar et al. 2008b; Murata 
and Nakazoe 2001). Contents of both total and species-specific polysaccharides show 
seasonal variations. The mannitol content varied markedly in the fronds of Saccharina and 
Laminaria species with maximum amounts found during summer and autumn, from June to 
November. The laminaran showed extreme variations during the year with very small 
amounts or none at all in February to June and maximum in September to November (Haug 
and Jensen 1954; Jensen and Haug 1956). The maximum content of alginic acid in the fronds 
of Saccharina and Laminaria species was generally found from March to June and the 
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minimum from September to October (Haug and Jensen 1954). However, highest contents of 
alginic acid were found during winter in other seasonal studies on Laminaria species from 
the same areas in Norway (Jensen and Haug 1956). 
Further investigations on the hydrolysates of some brown algae showed complex mixtures 
of monosaccharides. The components of galactose, glucose, mannose, fructose, xylose, 
fucose and arabinose were found in the total sugars in the hydrolysates. The glucose content 
was 65 %, 30 % and 20 % of the total sugars in an autumn sample of 50 individual plants of 
Saccharina, Fucus (serratus and spiralis) and Ascophyllum, respectively (Jensen 1956). 
Several other polysaccharides are present in and utilised from seaweed e.g. furcellaran, 
funoran, ascophyllan and sargassan, however these are not described in this chapter.  
Seaweed polysaccharides are separated into dietary fibres, hydrocolloids etc. in the 
following paragraphs, even though the polysaccharides belong to more than just one of the 
functional groups.  
2. Seaweed production and extraction 
Harvesting or aquaculture of marine algae or seaweeds is an extensive global industry. 
This seaweed industry provides a wide variety of products that have an estimated total 
annual production value of about US$ 6 billion. Food products for human consumption 
contribute about US$ 5 billion to this figure. Substances that are extracted from seaweeds – 
hydrocolloids – account for a large part of the remaining billion dollars, while smaller, 
miscellaneous uses, such as fertilizers and animal feed additives, make up the rest. The 
industry uses almost 20 million ton of wet seaweed annually (FAO, 2012 
http://www.fao.org/fishery/statistics/global-aquaculture-production/en), harvested either 
from naturally growing (wild) seaweed or from cultivated (farmed) crops. The farming of 
seaweed has expanded rapidly as demand has outstripped the supply available from 
natural resources. Commercial harvesting occurs in about 35 countries, spread between the 
northern and southern hemispheres, in waters ranging from cold, through temperate, to 
tropical (Mc Hugh, 2003). 
In Asia, seaweed cultivation is by far more important in terms of output and value than any 
other form of aquaculture. Looking at a global scale cultivated, seaweeds account for 87% of 
all seaweed harvested and processed of which the bulk is derived from aquaculture in Asia. 
The most valued of the cultivated seaweeds is the red alga Porphyra, or Nori. It is a major 
source of food for humans throughout the world, although it is almost exclusively cultivated 
in Japan, South Korea and China. Worldwide production has an annual value of over € 1.5 
billion. In addition to Porphyra, other edible seaweeds include Gracilaria, Undaria, Laminaria 
and Caulerpa with their collective value exceeding € 3.0 billion. New applications of seaweeds 
and specific seaweed compounds in different sectors, such as food supplements, cosmetics, 
biomedicine and biotechnology are developed (Chritchley et al., 2006) 
Seaweeds are also the industrial sources of polysaccharides such as carrageenans 
(Chondrus, Eucheuma and Kappaphycus), alginates (Ascophyllum, Laminaria, and 
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Macrocystis) and agars (Gelidium and Gracilaria; Table 2 ) and have a global value of 
approximately $ US 1 billion (Table 3). These important polysaccharides are used in the 
food, textile, paint, biotechnological and biomedical industries and have recently come 
under the spotlight as functional food ingredients. (Critchley et al., 2006).The majority of 
these species are used in some form for food or, in a few cases, for chemical extracts. The 
costs of production of the biomass tend to exceed the value of the biomass as a raw material 
for phycocolloid extraction, although it is known that some Chinese kelps produced by 
aquaculture are used for the production of salts of alginic acid, and applying low-
technology extensive forms of aquaculture are used to produce Gracilaria for agar extraction 
(table 2). The value of red seaweed produced by aquaculture showed a declining trend to 
US$1.3 - 1.4 billion over the 1997 - 2000 period. This is probably due to the high volumes of 
carrageenophytes Kappaphycus and Eucheuma produced by cultivation in south-east Asia 
and, to some extent, Gracilaria cultivated in South America, and as such, showing trends 
towards commoditization. 
3. Phycolloid industry 
The term phycocolloid is used to refer to three main products (alginate, carrageenan and 
agar) which are extracted from Brown and red seaweeds respectively. The estimated world 
market value for phycocolloids is $ US 1 Billion (Bixler and Porse, 2010). European output of 
phycocolloids is estimated to have an annual wholesale value of around €130 million which 
is 97.5% of the total for all algal products in Europe (Earons, 1994). 
3.1. Brown seaweeds and alginates 
Global alginate production is ca. 26,500 tons and valued at US$318 million annually, and is 
extracted from brown seaweeds, most of which are harvested from the wild. The more 
useful brown seaweeds grow in cold waters, thriving best in waters up to about 20 °C. The 
main commercial sources of phaeophytes for alginates are Ascophyllum, Laminaria, and 
Mycrocystis. Other minor sources include Sargassum, Durvillea, Eklonia, Lessonia, and 
Turbinaria (Bixler and Porse, 2010)..  
Brown seaweeds are also found in warmer waters, but these are less suitable for alginate 
production and are rarely used as food due to non-desirable chemical compounds such as 
terpenes. A wide variety of species are used, harvested in both the northern and southern 
hemispheres. Countries producing alginate include Argentina, Australia, Canada, Chile, 
Japan, China, Mexico, Norway, South Africa, the United Kingdom (mainly Scotland) and 
the United States. Most species are harvested from natural resources; cultivated raw 
material is normally too expensive for alginate production with the exception of China. 
While much of the Laminaria cultivated in China is used for food, when there is surplus 
production this can also be used in the alginate industry.  
Seaweed hydrocolloids, such as alginate, agar and carrageenan, compete with plant gums 
(such as guar and locust bean) and cellulose derivatives (such as carboxy methyl cellulose 
(CMC) and methyl cellulose) that are often cheaper.  
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Alginates are used in the manufacture of pharmaceutical, cosmetic creams, paper and 
cardboard, and processed foods (Chapman, 1970). Alginate represents the most important 
seaweed colloid in term of volume. Grades of alginate are available for specific applications. 
Sodium alginate, pharmaceutical grade (US$ 13-15.5 per kg), food grade (US$ 6.5-11.0 per 
kg). In Japan and Korea, high demands for Laminaria japonica (trade name kombu) have 
resulted in high prices and necessitated the import of supplies for alginate extraction 
(Critchley, 1998). Annual growth rate for alginates is ca. 2-3 percent, with textile printing 
applications accounting for about half of the global market. Pharmaceutical and medical 
uses are about 20 percent by value of the market and have stayed buoyant, with 2-4 percent 
annual growth rates, driven by ongoing developments in controlled release technologies 
and the use of alginates in wound care applications. Food applications are worth about 20 
percent of the market. That sector has been growing only slowly, and recently has grown at 
only 1-2 percent annually. The paper industry takes about 5 percent and the sector is very 
competitive, not increasing but just holding its own. The alginate industry faces strong 
competition from Chinese producers, whose prices do not reflect the real expense of 
cultivating Laminaria japonica, even in China, yet they do not appear to import sufficient 
wild seaweeds to offset those costs. The result is low profitability for most of the industry, 
with the best opportunities lying in the high end of the market, such as pharmaceutical and 
medical applications. 
3.2. Red seaweeds and Carrageenans  
Carrageenans are a group of biomolecules composed of linear polysaccharide chains with 
sulphate half-esters attached to the sugar unit. These properties allow carrageenans to 
dissolve in water, form highly viscous solutions, and remain stable over a wide pH range. 
There are three general forms (kappa, lambda and iota), each with their own gelling 
property. Kappa carrageenan today is almost exclusively obtained from farmed Kappaphycus 
alvarezii and iota from farmed Eucheuma denticulatum (Rasmussen and Morrissey 2007).  
The Carrageenan market is worth US$ 527 m with most Carrageenan used as human food-
grade semi-refined carrageenan (90%) and the rest going into pet food as semi-refined 
carrageenan. Chondrus crispus and Kappaphycus sp. are species containing up to 71 % and 
88 % of carrageenan, respectively (Chopin et al. 1999; Rodrigueza and Montaño 2007). Food 
applications for carrageenans (E 407) are many, including canned foods, desert mousses, 
salad dressings, bakery fillings, ice cream, instant deserts and canned pet-foods. In the 
1970s, an energy efficient process was developed in the Philippines to make a lower cost, 
strong-gelling kappa carrageenan and a weakly gelling iota. These semi-refined products 
gradually replaced the use of refined carrageenan as the gelling agent in canned meat pet 
foods. The process required lower capital investment than standard carrageenan refineries 
and the semi-refined extracts could be profitably sold for about two-thirds the price of 
conventionally refined carrageenan (Bixler and Porse, 2010). Industrial applications for 
purified extracts of carrageenans are equally diverse. They are used in the brewing industry 
for clarifying beer, wines and honeys, although less commonly than previously. There has 
been a fairly significant increase in production capacity for gel-press-refined carrageenan in 
recent years, particularly in Asia-Pacific.  
 
Algal Polysaccharides, Novel Applications and Outlook 495 
3.3. Red seaweeds and agar 
Agar is a mixture of polysaccharides, which can be composed of agarose and agropectin, 
with similar structural and functional properties as carrageenans. It is extracted from red 
seaweed such as Gelidium spp. and Gracilaria spp. (FAO 2008; Rasmussen and Morrissey 
2007; Jeon et al. 2005). A total of 9600 mt were sold in 2009 with a value of US$ 173 m. Agar–
agar is a typical and traditional food material in Japan and it is used as a material for 
cooking and Japanese-style confectionary. In addition, agar-agar is used in the manufacture 
of capsules for medical applications and as a medium for cell cultures, etc. Food applications 
continue to grow as shown by an increase of 2100 mt in over the last decade, and have been 
driven by the growth of processed foods in developing countries (Bixler and Porse, 2010). 
Agar melts and gels at higher temperatures than carrageenan so it finds uses in pastry 
fillings and glazes that can be applied before the pastry is baked without melting in the 
pastry oven. In processed meats, carrageenan is the favored water binder or texturing agent, 
but agar hold on to the gelatine replacement market in canned meats and aspics. The texture 
of agar in fruit jellies also compete with kappa carrageenan jellies, but the agar texture is 
preferred in parts of Asia, particularly in Japan. Although significantly smaller, the markets 
for the specialty grades are quite attractive because of better profit margins. Agarose, a 
sulfate-free very pure form of agar finds widespread use today in gel electrophoretic 
analysis of the molecules of biotechnology. 
4. Bioactive algal polysaccharides and functional properties  
While food has long been used to improve health, our knowledge of the relationship 
between food components and health is now being used to improve food. Strictly speaking, 
all food is functional, in that it provides energy and nutrients necessary for survival. But the 
term “functional food” in use today conveys health benefits that extend far beyond mere 
survival. Food and nutrition science has moved from identifying and correcting nutritional 
deficiencies to designing foods that promote optimal health and reduce the risk of disease.  
The combination of consumer desires, advances in food technology, and new evidence-
based science linking diet to disease and disease prevention has created an unprecedented 
opportunity to address public health issues through diet and lifestyle. Widespread interest 
in select foods that might promote health has resulted in the use of the term “functional 
foods.” Although most foods can be considered “functional,” in the context of this Chapter 
the term is reserved for algal polysaccharides that have been demonstrated to provide 
specific health benefits beyond basic nutrition, such as, alginates, agars, carrageenans, 
fucoidan, mannitol, laminarin, and ulvan. 
4.1. Dietary fibres 
The dietary fibres are very diverse in composition and chemical structure as well as in their 
physicochemical properties, their ability to be fermented by the colonic flora, and their 
biological effects on animal and human cells (Lahaye and Kaeffer 1997). Edible seaweed 
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contain 33-50 % total fibres on a dry weight basis, which is higher than the levels found in 
higher plants, and these fibres are rich in soluble fractions (Lahaye 1991). The dietary fibres 
included in marine algae are classified into two types, i.e. insoluble such as cellulose, 
mannans and xylan, and water soluble dietary fibres such as agars, alginic acid, furonan, 
laminaran and porphyran. The total content of dietary fibres is 58 % dry weight for Undaria, 
50 % for Fucus, 30 % for Porphyra and 29 % for Saccharina (Murata and Nakazoe 2001). Fucus 
and Laminaria have the highest content of insoluble dietary fibres (40 % and 27 % 
respectively) and Undaria pinnatifida (wakame), Chondrus and Porphyra have the highest 
content of soluble dietary fibres (15 % – 22 %; Fleury and Lahaye 1991).  
The undigested polysaccharides of seaweed can form important sources of dietary fibres, 
although they might modify digestibility of dietary protein and minerals. Apparent 
digestibility and retention coefficients of Ca, Mg, Fe, Na and K were lower in seaweed-fed 
rats (Urbano and Goñi 2002). The seaweed dietary fibres contain some valuable nutrients 
and substances, and there has been a deal of interest in seaweed meal, functional foods, and 
nutraceuticals for human consumption (McHugh 2003), because among other things 
polysaccharides show anti-tumour and anti-herpetitic bioactivity, they are potent as an anti-
coagulant and decrease low density lipid (LDL)-cholesterols in rats (hypercholesterolemia), 
they prevent obesity, large intestine cancer and diabetes, and they have anti-viral activities 
(Lee et al. 2004; Murata and Nakazoe 2001; Amano et al. 2005; Athukorala et al. 2007; Ghosh 
et al. 2009; Murata and Nakazoe 2001; Ye et al. 2008). Moreover, glucose availability and 
absorption are delayed in the proximal small intestine after the addition of soluble fibres, 
thus reducing postprandial glucose levels (Jenkins et al. 1978). Water insoluble 
polysaccharides (celluloses) are mainly associated with a decrease in digestive tract transit 
time (see also digestibility of polysaccharides; Mabeau and Fleurence 1993). 
4.2. Alginates 
Alginates were discovered in the 1880s by a British pharmacist, E.C.C. Stanford; industrial 
production began in California in 1929. Algins/alginates are extracted from brown seaweed 
and are available in both acid and salt form. The acid form is a linear polyuronic acid and 
referred to as alginic acid, whereas the salt form is an important cell wall component in all 
brown seaweed, constituting up to 40 % - 47 % of the dry weight of algal biomass (Arasaki 
and Arasaki 1983; Rasmussen and Morrissey 2007). Alginates are anionic polysaccharides. 
They contain linear blocks of covalently (1–4)-linked β-D-mannuronate with the C5 epimer 
α-L-guluronate. The blocks may contain one or both of the monomers and the ratio of 
monomers A and B, as well as a number of units (m and n) in a block is species dependent. 
It has been reported that alginic acid leads to a decrease in the concentration of cholesterol, 
it exerts an anti-hypertension effect, it can prevent absorption of toxic chemical substances, 
and it plays a major role as dietary fibre for the maintenance of animal and human health 
(Kim and Lee 2008; Murata and Nakazoe 2001; Nishide and Uchida 2003). These dietary 
polysaccharides are not found in any land plants. They help protect against potential 
carcinogens and they clear the digestive system and protect surface membranes of the stomach 
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and intestine. They absorb substances like cholesterol, which are then eliminated from the 
digestive system (Burtin 2003; Ito and Tsuchida 1972) and result in hypocholesterolemic and 
hypolipidemic responses (Kiriyama et al. 1969; Lamela et al. 1989; Panlasigui et al. 2003). This 
is often coupled with an increase in the faecal cholesterol content and a hypoglycaemic 
response (Dumelod et al. 1999; Ito and Tsuchida 1972; Nishide et al. 1993). 
Alginates, fucoidans and laminarin extracts were tested against nine bacteria, including 
Escerichia coli, Staphycococcus, Salmonella and Listeria. They appeared to be effective against E. 
coli and Staphylocococcus. Sodium alginate seemed to demonstrate a strong anti-bacterial 
element. It not only binds but also kills the bacteria. Studies conducted on seaweed extracts 
found that fucoidan appeared to function as a good prebiotic (a substance that encourages 
the growth of beneficial bacteria in the intestines). An anti-inflammatory effect from some of 
the extracts has also been found, and so far no toxic effects have emerged in use for human 
health (Hennequart 2007). Furthermore, alginates with molecular weights greater than or 
equal to 50 kDa could prevent obesity, hypocholesterolemia and diabetes (Kimura et al. 
1996). Clinical observations of volunteers who were 25 % - 30 % overweight showed that 
alginate, a drug containing alginic acid, significantly decreased body weight (Zee et al. 
1991). In type II diabetes treatment, taking 5 g of sodium alginate every morning was found 
to prevent a postprandial increase of glucose, insulin, and C-peptide levels and slowed 
down gastric transit (Torsdottir et al. 1991). Meal supplemented with 5 % kelp alginates 
decreased glucose absorption balance over 8 hours in pigs. Similar studies have been done 
on rats and humans (Vaugelade et al. 2000). Another health effect is that the binding 
property of alginic acid to divalent metallic ions is correlated to the degree of the gelation or 
precipitation in the range of Ba<Pb<Cu<Sr<Cd<Ca<Zn<Ni<Co<Mn<Fe<Mg. No intestinal 
enzymes can digest alginic acid. This means that heavy metals taken into the human body 
are gelated or rendered insoluble by alginic acid in the intestines and cannot be absorbed 
into the body tissue (Arasaki and Arasaki 1983).In several countries such as the USA, 
Germany, Japan, Belgium and Canada, the use of alginic acid and its derivatives for the 
treatment of gastritis and gastroduodenal ulcers, as well as the use of alginates as anti-ulcer 
remedies, is protected by patents (Bogentoff 1981; Borgo 1984; Reckitt and Colman Products 
Ltd 1987; Sheth 1967). Several products of alginate containing drugs have been shown to 
effectively suppress postprandial (after eating) and acidic refluxes, binding of bile acids and 
duodenal ulcers in humans. Examples are “Gaviscon” (sodium alginate, sodium 
bicarbonate, and calcium carbonate), “Algitec” (sodium alginate and cimetidine, an H2 
antagonist) and “Gastralgin” (alginic acid, sodium alginate, aluminium hydroxide, 
magnesium hydroxide and calcium carbonate) (Khotimchenko et al. 2001; Washington and 
Denton 1995). Clinical trials showed that sodium alginate promotes regeneration of the 
mucous membrane in the stomach, suppresses inflammation, eradicates colonies of 
Helicobacter pylori in the mucous membrane and normalizes non-specific resistance of the 
latter in 4 to 15-year-old children. It also promotes restoration of the intestinal biocenosis 
(Miroshnichenko et al. 1998). Other studies show positive dietry effects of alginates on faecal 
microbial fauna, changes in concentrations of compounds and acids, and prebiotic 
properties that can promote health (Terada et al. 1995; Wang et al. 2006). 
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Sodium alginate is often used as a powder, either pure or mixed with other drugs, on septic 
wounds. The polysaccharide base stimulates reparative processes, it prepares the wound for 
scarring, and it displays protective and coating effects, shielding mucous membranes and 
damaged skin against irritation from unfavourable environments. Calcium alginate 
promotes the proliferation of fibroblasts and inhibits the proliferation of microvascular 
endothelial cells and keratinocytes (Doyle et al. 1996; Glyantsev et al. 1993; Swinyard and 
Pathak 1985). Profound wound healing effects have also been reported for a gelatine-
alginate sponge impregnated with anti-septics and anti-biotics (Choi et al. 1999). 
Another use of alginates is the absorbing hemostatic effect exploited in surgery. Gauze 
dressings, cotton, swabs, and special materials impregnated with a solution of sodium 
alginate are produced and used for external use and for application onto bleeding points 
during abdominal operations on parenchymatous organs (Khotimchenko et al. 2001; 
Savitskaya 1986). Studies on the effect of alginate on prothrombotic blood coagulation and 
platelet activation have shown that the degree of these effects depends on the ratio between 
the mannuronic and guluronic chains in the molecule, as well as on the concentration of 
calcium. However, a zinc ion containing alginate was shown to have the most profound 
hemostatic effects (Segal et al. 1998). A “poraprezinc-sodium alginate suspension” has been 
suggested as a high performance mixture for the treatment of severe gingivostomatitis (cold 
sores) complicated by hemorrhagic erosions and ulcers (Katayama et al. 1998). When 
applied to the tooth surface, alginate fibres swell to form a gel like substance, a matrix for 
coagulation. Alginate dressings are used to pack sinuses, fistulas, and tooth cavities 
(Reynolds et al. 1982). 
Furthermore, the algins have anti-cancer properties (Murata and Nakazoe 2001) and a 
bioactive food additive “Detoxal”, containing calcium alginate, has anti-toxic effects on 
hepatitis. This drug decreases the content of lipid peroxidation products and normalizes the 
concentrations of lipids and glycogen in the liver (Khotimchenko et al. 2001).  
4.3. Carrageenans  
From a human health perspective it has been reported that carrageenans have anti-tumour 
and anti-viral properties (Skoler-Karpoff et al. 2008; Vlieghe et al. 2002; Yan et al. 2004; Zhou 
et al. 2006b). Furthermore, Irish Moss or Carrageen (C. crispus and Mastocarpus stellatus) has 
a large number of medical applications, some of which date from the 1830s. It is still used in 
Ireland to make traditional medicinal teas and cough medicines to combat colds, bronchitis, 
and chronic coughs. It is said to be particularly useful for dislodging mucus and has anti-
viral properties. Carrageenans are also used as suspension agents and stabilisers in other 
drugs, lotions and medicinal creams. Other medical applications are as an anti-coagulant in 
blood products and for the treatment of bowel problems such as diarrhoea, constipation and 
dysentery. They are also used to make internal poultices to control stomach ulcers 
(Morrissey et al. 2001). 
New research on the biocide properties shows that applications of carrageenan gels from 
C. crispus may block the transmission of the HIV virus as well as other STD viruses such as 
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gonorrhoea, genital warts and the herpes simplex virus (HSV) (Caceres et al. 2000; Carlucci 
et al. 1997; Luescher-Mattli 2003; Shanmugam and Mody 2000; Witvrouw and DeClercq 
1997). In addition, carrageenans are good candidates for use as vaginal microbicides because 
they do not exhibit significant levels of cytotoxicity or anti-coagulant activity (Buck et al. 
2006; Zeitlin et al. 1997). Results of sexual lubricant gels raised the possibility that use of 
such lubricant products, or condoms lubricated with carrageenan-based gels, could block 
the sexual transmission of HPV (human papillomavirus) types that can cause cervical cancer 
and genital warts. However, carrageenan inhibition of herpes simplex virus and HIV-1 
infectivity were demonstrated as about a thousand-fold higher than the IC50s observed for 
genital HPVs in vitro (Witvrouw and de Clerck 1997; Luescher-Mattli et al. 2003). A 
carrageenan-based vaginal microbicide called Carraguard has been shown to block HIV and 
other sexually transmitted diseases in vitro. Massive clinical trials by the Population Council 
Centre began in two severely affected African countries; Botswana and South Africa in 2002. 
Carraguard entered phase III clinical trials involving 6000 non-pregnant, HIV-negative 
women in South Africa and Botswana in 2003 (Spieler 2002). 
Many reports exist of anti-coagulant activity and inhibited platelet aggregation of 
carrageenan (Hawkins et al. 1962; Hawkins and Leonard 1963; Kindness et al. 1979). Among 
the carrageenan types, λ carrageenan (primarely from C. crispus) has approximately twice 
the activity of unfractioned carrageenan and four times the activity of κ-carrageenan 
(Eucheuma cottoni and E. spinosum). The most active carrageenan has approximately one-
fifteenth the activity of heparin (Hawkins et al. 1962), but the sulphated galactan from 
Grateloupa indica collected from Indian waters, exhibited anti-coagulant activity as potent as 
heparin (Sen et al. 1994). The principal basis of the anti-coagulant activity of carrageenan 
appeared to be an anti-thrombotic property. λ-carrageenan showed greater anti-thrombotic 
activity than κ-carrageenan, probably due to its higher sulphate content, whereas the 
activity of the unfractionated material remained between the two. It was found that toxicity 
of carrageenans depended on the molecular weight and not the sulphate content. Similar 
results were obtained with λ-carrageenan of Phyllophora brodiaei which gave the highest 
blood anti-coagulant activity (Sen et al. 1994). In addition, the hypoglycaemic effect of 
carrageenan may prove useful in the prevention and management of metabolic conditions 
such as diabetes (Dumelod et al. 1999).The use of carrageenan for food applications started 
almost 600 years ago. Due to its long and safe history of use, carrageenan is generally 
recognised as safe (GRAS) by experts from the US Food and Drug Administration (21 CFR 
182.7255) and is approved as a food additive (21 CFR 172.620). The World Health 
Organisation (WHO) Joint Expert Committee of Food Additives has concluded that it is not 
necessary to specify an acceptable daily intake limit for carrageenans (van de Velde et al. 
2002). Although carrageenans are used widely as a food ingredient, they are also used in 
experimental research in animals where they induce pleurisy and ulceration of the colon 
(Noa et al. 2000). Furthermore, carrageenans can cause reproducible inflammatory reaction 
and they remain a standard irritant for examining acute inflammation and anti-
inflammatory drugs. Two test systems are used widely for the evaluation of non-steroidal 
anti-inflammatory drugs and cyclooxygenase activity: (1) The carrageenan air pouch model 
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and (2) The carrageenan-induced rat paw edema assay (Dannhardt and Kiefer 2001). The 
role of carrageenans in promotion of colorectal ulceration formation is controversial and 
much seems to depend on the molecular weight of the carrageenan used. The international 
agency for research on cancer classified degraded carrageenan as a possible human 
carcinogen but native carrageenan remains unclassified in relation to a causative agent of 
human colon cancer and as mentioned it has GRAS status (Carthew 2002; Tobacman 2001).  
4.4. Agar 
The agar content in Gracilaria species can reach 31 % . It has been reported that agar-agar 
leads to decreases in the concentration of blood glucose and exerts an anti-aggregation effect 
on red blood cells. It has also been reported to affect absorption of ultraviolet rays (Murata 
and Nakazoe 2001). Anti-tumour activity was also found in an agar-type polysaccharide 
from cold water extraction of another Gracilaria species and hydrolysates of agar resulted in 
agaro-oligosaccharides with activity against α-glucosidase and antioxidant ability (Chen et 
al. 2005; Fernandez et al. 1989). Agarose can be separated from the agar with a yield of 42 %, 
and the agar content varied seasonally from 26 % - 42 % in Gelidium spp. in another 
experiment (Mouradi-Givernaud et al. 1992; Jeon et al. 2005). Agaro-oligosaccharides have 
also been shown to suppress the production of a pro-inflammatory cytokine and an enzyme 
associated with the production of nitric oxide (Enoki et al. 2003). 
4.5. Fucoidan/fucans/fucanoids 
Fucoidans are a group of polysaccharides (fucans) primarily composed of sulphated L-
fucose with less than 10 % of other monosaccharides. They are widely found in the cell walls 
of brown seaweed, but not in other algae or higher plants (Berteau and Mulloy 2003). 
Fucoidan is considered as a cell wall reinforcing molecule and seems to be associated with 
protection against the effects of desiccation when the seaweed is exposed at low-tide. 
Fucoidans were first isolated by Kylin almost one century ago and have interesting 
bioactivities (Kylin 1913). According to Table 4b the species Fucus vesiculosus contains the 
highest concentration of fucoidans (up to 20 % on a dry weight basis). Fucanoids can make 
up more than 40 % of dry weight of isolated algal cell walls and can easily be extracted 
using either hot water or an acid solution (Berteau and Mulloy 2003). Fucoidan is viscous in 
very low concentrations and susceptible to breakdown by diluted acids and bases. 
Fucoidans are produced as complex, heterogeneous polysaccharides, which contribute to 
intercellular mucilage. Their structural complexity varies in the degree of branching, 
substituents,sulfatation and type of linkages, the fine structure depending on the source of 
the polysaccharide. Although their composition varies with species and geographical origin, 
fucoidans always contain fucose and sulfate with small proportions of uronic acids, 
galactose, xylose, arabinose and mannose. Algal fucoidans have one of two types of 
homofucose backbone chains, with either repeated (13)-linked -L-fucopyranosyl residues 
or alternating (13)- and (14)-linked -L-fucopyranosyl residues  Cumashi et al 2007). 
Sulfonato- and acetyl-groups as well as -L-fucopyranosyl, -D-glucuronopyranosyl and 
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some other sugar residues may occur at O-2 and/or at O-4 of the -L-fucose units of the 
backbone. Fucoidans with backbones of first type have been isolated from seaweeds 
Saccharina latissima, Laminaria digitata, Chorda filum, and Cladosiphon okamuranus. The second 
type of backbone was found in fucoidans from Fucus evanescense, Fucus distichus, and 
Ascophyllum nodosum. 
A Tasmanian company, Marinova Pty Ltd, is able to supply commercial volumes of 
fucoidan extract and their derivates, formulated to purity levels of up to 95 %. All fucoidans 
of the species Undaria sp., Lessonia sp., Macrocystis sp., Cladosiphon sp., Durvillea sp., 
Laminaria sp., Ecklonia sp., Fucus sp., Sargassum sp., Ascophyllum sp., and Alaria sp. are Halal 
and Kosher certified. Marinova has isolated fucoidans from a range of species (species-
specific), and can provide characterised fractions for either investigational research or as 
ingredients for nutraceutical and cosmetic applications. Different therapeutic profiles are 
primarily due to the molecular structure. The company has developed the Maritech™ 
coldwater extraction process, which maintains the integrity of fucoidans, and produces 
nature-equivalent high molecular weight molecules with optimal bioactivity. Solvent-based 
extraction, which is commonly used, causes degradation of fucoidans, and limits the activity 
of these molecules in biological assays.  
Sector % Demand Sector Growth Ton Value US$ 
Textile printing and 
technical grades 
41.5 Flat 11,000 140.0m 
Food and Pharma 49 60% 13,000   150.0m 
Animal feed 3.8 -75%   1,000   18.0m 
PGA 5.7 -25%   1,500   10.0m 
Total  100  26,500 $318m 
Table 4. Alginate markets (2009) – Tonnage, value and sector growth over last decade (Data; Bixler and 
Porse, 2010) 
Although the major physiological purposes of fucans in the algae are not thoroughly 
understood, they are known to possess numerous biological properties with potential 
human health applications (Berteau and Mulloy 2003). The list of bioactivity of fucoidan for 
human health is long. Fucoidan found in seaweed such as Undaria and Laminaria shows anti-
coagulant, anti-viral and anti-cancer properties; Chevolot et al. 1999; Zhuang et al. 1995). 
Fucoidan preparations have been proposed as an alternative to the injectable anti-coagulant 
heparin, because fucoidan originates from plant matter and is less likely to contain 
infectious agents such as viruses (Berteau and Mulloy 2003). No toxicological changes were 
observed when 300 mg/kg body weight per day fucoidan was administered to rats, 
however, significantly prolonged blood-clotting times were observed when concentrations 
were increased three-fold (Li et al. 2005). The biological activity (e.g. antioxidant and anti-
coagulant) of sulphated polysaccharides is not only related to molecular weight and 
sulphated ester content (role in the charge of the molecule), as previously determined, but 
also to glucuronic acid and fucose content, together with the position of the sulphate groups 
on the sugar resides (Berteau and Mulloy 2003; Li et al. 2005; Zhao et al. 2008). A large 
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molecular weight is required to achieve anti-coagulant activity, as fucoidan needs a long 
sugar chain in order to be able to bind the thrombin (coagulation protein in the blood 
stream). Some researchers have measured fucoidan’s molecular weight at approximately 100 
kDa. while others have observed a molecular weight of 1600 kDa (Rioux et al. 2007). The 
native fucoidan from Lessonia vadosa with a molecular weight of 320 kDa showed good anti-
coagulant activity compared to a smaller depolymerised fraction with a molecular weight of 
32 kDa, which presented weaker anti-coagulant activity (Li et al. 2008a). Some structural 
features of fucoidan are most likely required for certain specific activities.  
Fucoidan stimulates the immuno system in several ways, and the numerous important 
biological effects of fucoidans are related to their ability to modify cell surface properties 
(Usov et al. 2001). Oral intake of the fucoidans present in dietary brown seaweed might take 
the protective effects through direct inhibition of viral replication and stimulation of the 
immune system (innate and adaptive) functions (Hayashi et al. 2008). Fucoidan has been 
found to restore the immune functions of immune-suppressed mice, act as an 
immunomodulator directly on macrophage, T lymphocyte, B cell, natural killer cells (NK 
cell; Wang et al. 1994), promote the recovery of immunologic function in irradiated rats (Wu 
et al. 2003), induce the production of interleukin (IL-1) and interferon-γ (IFN-γ) in vitro, and 
promote the primary antibody response in sheep red blood cells in vivo (Yang et al. 1995). 
The mechanism of anti-viral activities of fucoidan is to inhibit viral sorption so as to inhibit 
viral-induced syncytium formation (Mandal et al. 2007). Sulphate is necessary for the anti-
viral activity and sulphate located at C-4 of (1-3)-linked fucopyranosyl units appears to be 
very important for the anti-herpetic activity of fucoidan (Mandal et al. 2007). Some anti-viral 
properties of sulphated fucans have also been characterised, for example inhibition of 
infection of human immunodeficiency virus (HIV), Herpes Simplex Virus (HSV) (Iqbal et al. 
2000; Mandal et al. 2007; Witvrouw and DeClercq 1997), poliovirus III, adenovirus III, 
ECH06 virus, coxsackie B3 virus, coxsackie A16 (Li et al. 1995), cytomegalovirus and bovine 
viral diarrhea virus (Iqbal et al. 2000).  
Fucoidan is known to have anti-tumour effects but its mode of action is not fully 
understood. A study done by Alekseyenko et al. 2007 demonstrated that when 10 mg/kg of 
fucoidan was administered in mice with transplanted Lewis lung adenocarcinoma, it 
produced moderate anti-tumour and anti-metastatic effects (Li et al. 2008b). These 
polyanionic polysaccharides have anti-angiogenesis, antiproliferation for tumour cells, they 
inhibit tumour growth and reduce tumour size (Ellouali et al. 1993; Li et al. 2008a), inhibit 
tumour cell adhesion to various substrata (Liu et al. 2005), and have direct anti-cancer effects 
on human HS-Sultan cells through caspase and ERK pathways (Aisa et al. 2005).  
Besides directly inhibiting the growth of tumour cells, fucoidans can also restrain the 
development and diffusion of tumour cells through enhancing the body’s immuno-
modulatory activities, because fucoidan mediates tumour destruction through type 1 T-
helper (Th1) cell and NK cell responses (Maruyama et al. 2007). In addition, at a dose of 
25 mg/kg, fucoidan potentiated the toxic effect of cyclophosphamide used to treat various 
types of cancer and some auto-immune disorders (Alekseyenko et al. 2007). 
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Many studies suggest that fucoidan has potential for use as an anti-inflammatory agent. A 
study showed that fucoidan treatment led to less severe symptoms in the early stages of 
Staphylococcus aureus-triggered arthritis in mice, but delayed phagocyte recruitment and 
decreased clearance of the bacterium (Verdrengh et al. 2000). Additionally, injection of 
fucoidan into sensitized mice before hapten challenge can reduce contact hypersensitivity 
reactions (Nasu et al. 1997). Furthermore, recruitment of leukocytes into cerebrospinal fluid 
in a meningitis model is reduced by fucoidan (Granert et al. 1999) as is IL-1 (interleukin-1) 
production in a similar model (Ostergaard et al. 2000).  
Fucoidan can act as a ligand for either L- or P- selectins, both of which interact with the 
sulphated oligosaccharides and this interaction has physiological consequences that could 
be therapeutically beneficial (Omata et al. 1997). Selectins are a group of lectins (sugar-
binding proteins) that interact with oligosaccharides clustered on cell surfaces during the 
margination and rolling of leukocytes prior to firm adhesion, extravasation and migration to 
sites of infection (Lasky 1995). 
In addition, fucoidan is an excellent natural antioxidant and presents significant antioxidant 
activity in experiments in vitro. In recent years, sulphated polysaccharides from the marine 
algae Porphyra haitanesis (Zhang et al. 2003), Ulva pertusa (Qi et al. 2005b; Qi et al. 2005a), 
Fucus vesiculosus (Ruperez et al. 2002), Laminaria japonica (Xue et al. 2004) and Ecklonia 
kurome (Hu et al. 2001) have been demonstrated to possess antioxidant activity. There are 
few reports however detailing the relationship between structure and antioxidant activity of 
sulphated polysaccharides from marine algae. Fucan showed low antioxidant activity 
relative to fucoidan (Rocha de Souza et al. 2007) and as mentioned previously, the ratio of 
sulphate content/fucose and the molecular weight were effective indicators to antioxidant 
activity of the samples (Wang et al. 2008). Fucoidan may have potential for preventing free 
radical mediated diseases such as Alzheimer’s and the aging process. Previously, fucoidan 
was extracted from L. japonica, a commercially important algae species in China. Three 
sulphated polysaccharide fractions were successfully isolated through anion-exchange 
column chromatography and had their antioxidant activities investigated employing 
various established in vitro systems, including superoxide and hydroxyl radical scavenging 
activity, chelating ability, and reducing power (Wang et al. 2008). All fractions were more 
effective than the unprocessed fucoidan. Two galactose-rich fractions had the most potent 
scavenging activity against superoxide (generated in the PMS-NADH system) and hydroxyl 
radicals with EC50 values of 1.7 μg mL-1 and 1.42 mg mL-1, respectively. One of these 
fractions also showed the strongest ferrous ion chelating ability at 0.76 mg mL-1 (Wang et al. 
2008). Additionally, fucoidan (homofucan) from F. vesiculosus and fucans (heterofucans) 
from Padina gymnospora had an inhibitory effect on the formation of hydroxyl radical and 
superoxide radical (Rocha de Souza, et al. 2007). Healing of dermal wounds with 
macromolecular agents such as natural polymers is a growing area of research interest in 
pharmaceutical biotechnology. Fucoidan has been shown to modulate the effects of a variety 
of growth factors through mechanisms thought to be similar to the action of heparin. 
Fucoidan-chitosan films can promote re-epithelization and contraction of the wound area. 
Moreover, fucoidan-chitosan films may be suitable for use in hydrogel formulations for the 
treatment of dermal burns (Sezer, et al. 2007). 
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4.6. Mannitol 
Mannitol is an important sugar alcohol which is present in many species of brown algae, 
especially in Laminaria and Ecklonia. The mannitol content is subject to wide seasonal 
fluctuations and varies with environment. Mannitol is the sugar alcohol corresponding to 
mannose. It usually constitutes less than 10 % of the dry weight in both Ascophyllum nodosum 
and L. hyperborea stipe. In autumn fronds of L. hyperborea, however, the content may be as 
high as 25 % of the dry weight . 
Applications of mannitol are extremely diverse. It is used in pharmaceuticals, in making 
chewing gum, in the paint and varnish industry, in leather and paper manufacture, in the 
plastics industry and in the production of explosives. The US, the UK, France and Japan are 
the main centres of production. Mannitol can be used in a variety of foods, candies and 
chocolate-flavoured compound coatings because it can replace sucrose to make sugar-free 
compound coatings. Sugar-free chocolates are especially popular for people with diabetes, a 
growing problem in modern society. It is used as a flavour enhancer because of its sweet 
and pleasantly cool taste. Mannitol can be used to maintain the proper moisture level in 
foods so as to increase shelf-life and stability, because it is non-hygroscopic and chemically 
inert. Mannitol is the preferred excipient for chewable tablets due to its favourable feel in 
the mouth. It is non-carcinogenic and can be used in pediatric and geriatric food products, 
as it will not contribute to tooth decay (Nabors 2004). 
4.7. Laminarin 
Laminaran is a glucan, built up from (13)- and (16)-β-glucose residues. It is a linear 
polysaccharide, with a β(13):β(16) ratio around 3:1. Laminarin is found in the fronds of 
Laminaria/Saccharina and, to a lesser extent, in Ascophyllum and Fucus species and 
Undaria. The content varies seasonally and with habitat and can reach up to 32 % of the dry 
weight. Laminaran does not gel nor form any viscous solution and its main potential 
appears to lie in medical and pharmaceutical uses. 
Commercial applications of the extract have so far been limited, although some progress has 
been made in France as an anti-viral in agricultural applications (Goemar 2010) or as dietary 
fiber (Deville et al. 2004). Especially the use of laminarin as substratum for prebiotic bacteria 
seems to have a good commercial application (Deville et al. 2004). Laminarin does not gel or 
form any viscous solution, and its main potential appears to lie in medical and 
pharmaceutical uses. It has been shown to be a safe surgical dusting powder, and may have 
value as a tumour-inhibiting agent and, in the form of a sulphate ester, as an anti-coagulant 
(Miao et al. 1999). The presence of anti-coagulant activity in brown algae was first reported 
in 1941, when Laminaria showed anti-coagulant properties with its active compound being 
located in the holdfasts (Shanmugam and Mody 2000). There are about 60 brown algal 
species identified to have blood anti-coagulant properties. Laminarin only shows anti-
coagulant activity after structural modifications such as sulphation, reduction or oxidation. 
The anti-coagulant activity is improved chemically by increasing the degree of sulphation 
(Shanmugam and Mody 2000). 
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Preparations containing 13:16-β-D-glucans, laminarin, and fucoidan are manufactured 
by the health industry and marketed for their beneficial properties on the immune system. 
The producers of these tablets cite numerous papers discussing the biological activity of 
these glucans.  
Laminarin provides protection against infection by bacterial pathogens, and protection 
against severe irradiation, it boosts the immune system by increasing the B cells and helper 
T cells, reduces cholesterol levels in serum and lowers systolic blood pressure, among other 
effects (Table 4c; Hoffman et al. 1995) lower the levels of total cholesterol, free cholesterol, 
triglyceride and phospholipid in the liver (Miao et al. 1999; Renn et al. 1994a; 1994b). The 
hypocholesterolemic and hypolipidemic responses are noted to be due to reduced 
cholesterol absorption in the gut (Kiriyama et al. 1969; Lamela et al. 1989; Panlasigui et al. 
2003). This is often coupled with an increase in the faecal cholesterol content and a 
hypoglycaemic response (Dumelod et al. 1999; Ito and Tsuchida 1972; Nishide et al. 1993). A 
high level of low density lipid (LDL) cholesterol can lead to plaque forming and clog 
arteries and lead to cardiovascular diseases and heart attacks or strokes, a major cause of 
disease in the US. Laminarin as a potential cancer therapeutic is under intensive 
investigation (Miao et al. 1999). 
4.8. Ulvan 
The name ulvan is derived from the original terms ulvin and ulvacin introduced by Kylin in 
reference to different fractions of Ulva lactuca water-soluble sulphated polysaccharides. It is 
now being used to refer to polysaccharides from members of the Ulvales, mainly, Ulva sp. 
Ulvans are highly charged sulphated polyelectrolytes, composed mainly of rhamnose, 
uronic acid and xylose as the main monomer sugars, and containing a common constituting 
disaccharide; the aldobiuronic acid, [4)-D-glucuronic acid-(14)- L-rhamnose3-sulfate-
(1]. Iduronic acid is also a constituent sugar. The average molecular weight of ulvans 
ranges from 189 to 8,200 kDa (Lahaye 1998). The cell-wall polysaccharides of ulvales 
represent 38 % to 54 % of the dry algal matter (Lahaye, 1998). Two major kinds have been 
identified: water soluble ulvan and insoluble cellulose-like material.  
The mechanism of gel formation is unique among polysaccharide hydrogels. It is very 
complex and not yet fully understood. The viscosity of ulvan solutions as isolated 
polysaccharides has been compared to that of arabic gum. Whether ulvans present other 
functional properties of this gum remains to be established. The gelling properties of ulvans 
are affected by boric acid, divalent cations and pH. They are thermoreversible without 
thermal hysteresis. The gelling properties can be of interest for applications where gel 
formation needs to be precisely controlled (by pH or temperature), like the release of 
trapped molecules or particles under specific conditions (Percival and McDowell 1990; 
Lahaye et al. 1998). As already mentioned, highly absorbent, biodegradable hydrocolloid 
wound dressings limit wound secretions and minimise bacterial contamination. 
Polysaccharide fibres trapped in a wound are readily biodegraded. In the context of BSE 
(mad cow disease) and other prion contamination diseases, macromolecular materials from 
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algal biomasses such as ulvans can constitute an effective and low-cost alternative to meat-
derived products, because their rheological and gelling properties make them suitable as a 
substitute for gelatin and related compounds (Choi et al. 1999). 
Ulvans are a source of sugars for the synthesis of fine chemicals. In particular, they are a 
potential source of iduronic acid, the only occurrence to date of this rare uronic acid in 
plants (Lahaye and Ray 1996). Iduronic acid is used in the synthesis of heparin fragment 
analogues with anti-thrombotic activities, and obtaining it requires a lengthy synthetic 
procedure that could be more cost-effectively replaced by a natural source (Lahaye 1998). 
Oligosaccharides from Ulva could be used as reference compounds for analyzing 
biologically active domains of glycosaminoglycans (GAG) like heparin. The use of oligo-
ulvans as anti-coagulant agents could be expected since other, rarer, sulphated 
polysaccharides, like dermatan sulphate or fucan in brown algae, have shown this anti-
thrombinic activity. Regular oligomers from ulvans may provide better-tolerated anti-
thrombinic drugs (Paradossi et al. 2002). 
Rhamnose, a major component of ulvans, is a rare sugar, used as a precursor for the 
synthesis of aroma compounds. Combinatorial libraries in glycopeptide mimetics are 
another example of the use of L-rhamnose in the pharmaceutical industry. The production 
of rhamnose from Monostroma, a Japanese species of Codiales, has been patented. Rare 
sulphated sugars such as rhamnose 3-sulphate and xylose 2-sulphate are also of interest 
(Lahaye and Robic 2007). 
Other potential applications of ulvan oligomers and polymers are related to their biological 
properties. Recent studies have demonstrated that ulvans and their oligosaccharides were 
able to modify the adhesion and proliferation of normal and tumoural human colonic cells 
as well as the expression of transforming growth factors (TGF) and surface glycosyl markers 
related to cellular differentiation (Lahaye and Robic 2007) . Earlier work demonstrated 
strain-specific anti-influenza activities of ulvan from U. lactuca and the use of rhamnan, 
rhamnose and oligomers from desulphated Monostroma ulvans has been patented for the 
treatment of gastric ulcers (Fujiwara-Arasaki et al. 1984; Nagaoka et al. 2003).  
Oligomers from seaweed species such as Laminaria sp. or Fucus serratus have also been 
studied as plant elicitors. These are natural compounds which stimulate the natural 
defences of plants. Several products derived from brown algae are already marketed 
worldwide. The success is because of their size and availability rather than their chemical 
composition. Ulva cell walls bind heavy metals and ulvans are the main contributors with 
2.8 to 3.77 meq g-1 polysaccharide. The ion-exchange property of ulvans explains why they 
have been chosen as bioindicators for monitoring heavy metal pollution in coastal waters 
(Nagaoka et al. 1999). 
4.9. Porphyran and Xylans 
In red algae, the fibrillar network is made of low crystalline cellulose, mannan or xylan and 
represents only about 10% of the cell wall weight. It can also contain minor amounts of 
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sulphated glucans, mannoglycans and complex galactans. Most of our current knowledge of 
red algal cell wall polysaccharides is on the gelling and thickening water soluble galactans, 
agars and carrageenans, used in various applications. Unlike most red seaweed generally 
studied, Palmaria palmata does not produce matrix galactans, but instead (10/4)- and (10/3)-
linked b-D-xylan together with a minor amount of fibrillar cellulose and b-(10/4)-Dxylan. 
Xylans can be 35 % of the dry weight of Palmaria (Lahaye et al. 2003). Xylans have not yet 
been of economic interest and only few applications are known. Species of Porphyra contain 
a sulphated polysaccharide called porphyran; a complex galactan. Porphyran is dietary fiber 
of good quality, and chemically resembles agar. A powder consisting of 20 % nori mixed 
with a basic diet given orally to rats prevented 1,2-dimethylhydrazine-induced intestinal 
carcinogenesis. Porphyran showed appreciable anti-tumour activity against Meth-A 
fibrosarcoma. In addition, it can significantly lower the artificially enhanced level of 
hypertension and blood-cholesterol in rats (Noda 1993). 
4.10. Digestibility of polysaccharides 
The majority of edible seaweed fibres are soluble anionic polysaccharides which are little-
degraded or not fermented by the human colonic micro flora (Lahaye and Kaeffer 1997). The 
amount of dietary fibres in marine algae not digested by the human digestive tract is higher 
than that of other food materials (Murata and Nakazoe 2001). Most of the total algal fibres 
disappeared after 24 h (range 60 % - 76 %) in in vitro fermentation of e.g. L. digitata and 
U. pinnatifida using human faecal flora. However, unlike the reference substrate (sugar beet 
fibres), the algal fibres were not completely metabolized to short chain fatty acids (SCFA; 
range 47 % - 62 %). Among the purified algal fibres, disappearance of laminarins was 
approximately 90 % and metabolism to SCFA was approximately 85 %, in close agreement 
with the fermentation pattern of reference fibres. Sulphated fucans were not degraded. 
Sodium alginates (Na-alginates) exhibited a fermentation pattern quite similar to that of the 
whole algal fibres, with a more pronounced discrepancy between disappearance and 
production of SCFA: disappearance was approximately 83 % but metabolism was only 
approximately 57 %. Laminarin seemed to be a modulator of the intestinal metabolism by its 
effects on mucus composition, intestinal pH and short chain fatty acid production, 
especially butyrate. The characteristic fermentation pattern of the total fibres from the 
brown algae investigated was attributed to the peculiar fermentation of alginates (Michel et 
al. 1996; Deville et al. 2007). 
Phycolloids are more or less degraded following adaptation of the human micro flora, but 
none of the seaweed polysaccharides have been shown to be metabolized, although some 
may be partly absorbed. Nothing is known about the fate of other algal polysaccharides in 
the human digestive tract, except that they cannot be digested by human endogenous 
enzymes. Results of fermentation in vitro with human faecal bacteria, indicate that brown 
seaweed fibres exhibit an original fermentation pathway (Mabeau and Fleurence 1993). 
Carrageenan is a good source of soluble fibre (Burtin 2003). Rats excrete carrageenan 
quantitatively in the faeces, if it is administered in the diet at levels of 2 % - 20 % and it 
therefore has no direct nutritive value (Hawkins and Yaphe 1965). Weight gain was 
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significantly reduced, especially at higher levels. Furthermore, food efficiency showed 
interference with utilization of other nutrients in the diet. Only 10 % - 15 % appeared 
digestible from faecal examination (Hawkins and Yaphe 1965). An experimental feeding 
with L  digitata seaweed extract in pig resulted in a higher production of butyric acid in the 
caecum and colon compared to the control group (Reilly et al. 2008). Butyrate is a beneficial 
metabolite for intestinal bacteria, because it is quickly metabolised by colonoyctes and 
accounts for about 70 % of total energy consumption of the colon (Reilly et al. 2008). 
Therefore, it is desirable to promote butyrate production in the colon by laminarin 
fermentation.  
The particular chemical structure of ulvan (and of Ulva) is responsible for the resistance of 
this polysaccharide to colonic bacterial fermentation. Consumption of dietary fibres from 
Ulva sp. could be expected to act mainly as bullring agents with little effect on nutrient 
metabolism due to colonic bacterial fermentation products (short-chain fatty acids; Bobin-
Dubigeon et al. 1997). All soluble fibre fractions of P palmata consisted of linear beta-
1,4/beta1,3 mixed linked xylans containing similar amounts of 1,4 linkages (70.5 % - 80.2 %). 
The insoluble fibres contained essentially 1,4 linked xylans with some 1,3 linked xylose and 
a small amount of 1,4-linked glucose (cellulose). Soluble fibres were fermented within 6 
hours by human faecal bacteria into short chain fatty acids (Lahaye et al. 1993). 
4.11. Commercial products, patents and applications 
Due to their plethora of bioactive molecules, marine macroalgae have great potential for 
further development as products in the nutraceutical, functional food, and pharmaceutical 
markets. Patent activity in this area has increased and several novel products based on 
macroalgae have entered the market in recent years. In respect of carbohydrates for 
example, the Kabushiki Kaisha Yakult Honsha company, Japan has patented a 
polysaccharide derivative (which contains fucoidan and rhamnan or rhamnan sulphate 
polysaccharides), extracted from the marine brown macroalgae, such as, Cladosiphon 
okamuranus, Chordaricles nemacystus, Hydrilla sp., Fucus sp., and a green alga Monostroma 
nitidum. The purpose of this compound is as a therapeutic agent for the prevention and 
treatment of gastric ulcers (specifically inhibiting the adhesion of Helicobacter pylori and 
administered as tablets, granules, powders or capsules (Nagaoka et al., 2003). Furthermore, 
Takara Shuzo Company, Kyoto, Japan has developed a medicinal composition exemplified 
by viscous polysaccharides isolated from red algae (specifically: Gelidium amansil, G. 
japonicum, G. pacificum, G. subcostatum, Pteocladia tennis and Hypneaceae species consisting of 
at least one 3,6- anhydrogalactopyranose. This compound is proposed for the treatment or 
prevention of diabetes, rheumatism, cancer and contains various inhibitory factors (Enoki et 
al., 2003). Sulphated fucans from Fuscus vesiculosis and Ascophyllum nodosum have been 
patented as anticoagulant substances (Smit, et al., 2004). In practical gastroenterology, 
mixtures of alginic acid and alginates with antacids are used to prevent gastro-esophageal 
reflux and to cure epigastric burning (Klinkenberg- Knol et al., 1995; Zeitoun et al., 1998). 
Indeed, in several countries such as the US, Germany, Japan, Belgium and Canada the use of 
alginic acid and its derivatives for the treatment of gastritis and gastroduodenal ulcers, as 
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well as the use of alginates as atiulcer remedies, is protected by patents (Bogentoff et al, 
1981; Borgo et al., 1984; Reckitt et al., 1987; Sheth et al., 1967). The medical application of 
pure fucoidan fraction has also been patented by the French research institute IFREMER-
CNRS (PATENT WO/32099, however the extract of brown seaweeds (containing fucoidan 
fractions) can still be applied in cosmetology as fibroblast proliferation activators in the 
context of treatments aimed at aesthetics, for example of antiwrinkle treatments or of 
prevention of skin ageing without patent infringement. 
 
Company  Compound Activity / disorder Development  
Various  Heparin and derivatives  Anti-coagulants  Since 1940’s  
Astellas  Auranofin (Ridaura)  Anti-rheumatic  1983  
GSK  Zanamivir (Relenza)  Anti-influenza  1992  
Johnson & Johnson  Topiramate (Topamax)  Anti-epileptic  1987  
Bayer  Acarbose (Glucobay)  Type II diabetes  1990  
 (Pseudo-oligosaccharide)  (a-glucosidase, a-  
  amylase inhibitor)   
Ortho-McNeil Janssen Elmiron (Pentosan  Cystitis (for CJD)  1996  
Pharmaceutical  polysulfate)    
Alfa Wassermann  Sulodexide (Vessel™)  cardiovascular  Marketed since 
  indications  1980’s  
Hunter Fleming 
(now Newron)  
HF0420 – low MWt  
oligosaccharide  
neuroprotective  Phase I  
Progen (Australia)  PI-88  Anti-angiogenic/anti- Phase III  
 (Phosphomannopentaose  metastatic.   
 sulphate, Heparan sulfate  (hepatocellular   
 mimetics)  carcinoma)   
PG500 series  Anti-angiogenic/anti- Preclinical  
 (Heparan sulfate  metastatic.   
 mimetics)    
Endotis Pharma  EP42675 (org)  Anticoagulant  Phase I  
 EP224283 (org)  Neutralizable   
  antithrombotic  Preclinical  
EP37  venous and arterial  Preclinical  
  thromboses   
EP8000 programme  Anti-angiogenesis, anti- Preclinical  
  tumour growth   
  /metastasis   
Biotec Pharmacpn  SBG (Soluble beta glucan  Immune stimulation  GRAS  
(Norway)  – beta-1,3/1,6 glucan)  Anti-cancer  nutraceutical  
Table 5. Examples of carbohydrate-based drugs in use or development 
The macroalgae polysaccharides described in this chapter show that these can be an 
interesting natural source of potential functional ingredients. As the content of proteins, 
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carbohydrates, lipids and fiber can be influenced by the growing parameters (water, 
temperature, salinity, light and nutrients), macroalgae can be considered bioreactors that 
may be able to provide different polysaccharides at different quantities (Rui et. Al., 1990). 
From the descriptions above it is clear that macroalgae polysaccharides possess a multitude 
of bioactivities that might have antioxidant, antibacterial, antiviral, anticarcinogenic, 
anticoagulant and other bioactive properties for use as functional foods, pharmaceuticals 
and cosmeceuticals. The use of carbohydrate-based drugs is in its infancy, although there 
are several well-known examples (Table 5). Heparin is the key example of a major 
medicinally used carbohydrate based molecule. Low molecular weight heparins (eg. 
Certoparin, Dalteparin) and various derivatives (Fondaparinux – fully synthetic) have been 
developed to improve efficacy and half-life, and some are now being trialed for non-
thrombotic/vascular applications (eg. Certoparin for inflammatory aspects of Alzheimers 
disease). It is only comparatively recently that the anti-inflammatory properties of heparin 
have been discovered. The presence of abundant 3-O-sulfated glucosamines in Heparan 
sulfates from human follicular fluid has suggested that some biological activities could be 
mimicked by other sulfated polysaccharides or derivatives (de Agostini et al., 2008). Low 
molecular weight fucoidan (LMWF) has been used to demonstrate this (Colliec et al., 1991, 
Millet et al., 1999 and Durand et al., 2008). 
The drugs listed in Table 5 have overcome some of the perceived limitations of sugar-based 
molecules in terms of delivery, synthesis and immunogenicity. Although many still require 
intravenous delivery, several are available orally (e.g. Pentosan polysulfate), and further 
research is targeting to the improvement of oral availability by reducing compounds to their 
smallest active components, or by combining with other molecules (e.g. sulodexide). 
Improved synthesis has meant that some compounds can be synthesised (e.g. 
Fondaparinux), and small active components can be selected or modified to improve 
efficacy. No major problems have been reported with immunogenicity either in animal trials 
or as approved drugs. Sulphated polysaccharides may also be good anticoagulants through 
non-antithrombin mediated mechanisms, such as inhibition of thrombin mediated by 
heparin cofactor II (HC2). Like heparin, sulphated polysaccharides modulate cell growth-
related activities, with inhibitory or promoting effects, depending on their carbohydrate 
backbones, degrees of sulphation, and distribution of sulphate groups. These activities can 
be usefully modulated through modification of sulphation patterns (Casu et al., 2002; Naggi 
et al., 2005). Several biological activities of sulphated polysaccharides are also molecular 
weight-dependent and the average length of their chains should be carefully controlled in 
order to maximize the desired activity. In some systems, opposite activities can be achieved 
with chains of different lengths of the same sulphated polysaccharide. Typically, relatively 
small oligosaccharides of heparin and heparinoids bind to growth factors and act as 
inhibitors of angiogenesis. On the other hand, the corresponding highermolecular weight 
species induce growth factors activation through oligomerization and binding with their 
receptors, thus promoting cell growth signalling (Casu and Lindahl, 2002; Goodner et al., 
2008). Also inhibiton of heparanase and heparanase-related biological activities such as 
angiogenesis and metastasis by heparin species (Naggi et al., 2005) and sulfated 
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hyaluronates (Naggi et al., 2005) are dependent on molecular weights and sulfation patterns. 
Similarly, sulphated polysaccharides are expected to be exploitable as drugs either in their 
natural form or with depolymerization and/or chemical derivatisation. Macroalgal suphated 
polysaccharides need to be fully characterised and the biological activities associated with 
specific structures determined so that their development can progress. 
5. Brown algae – Growth, cultivation and productivity 
Due to the relatively high carbohydrate content in percentage of the dryweight (Table 1) 
brown macroalgae in particular species of the Laminariaceae have come under the spotlight 
for mass-cultivation. Specifically  in respect of carbohydrate production for fermentation 
purposes for ethanol and or biodegradable plastics production or other medical and food 
applications. Brown macroalgae exploitation in Europe is currently restricted to manual and 
mechanised harvesting of natural stocks, although several EU projects explore mass 
cultivation in European waters. The majority of Asian seaweed resources are cultivated. The 
most common system in Europe to obtain seaweed biomass is by harvesting natural stocks 
in coastal areas with rocky shores and a tidal system. The natural population of seaweed is a 
significant resource. Depending on water temperature, some groups will dominate, like 
brown seaweeds in cold waters and reds in warmer waters. In Europe the main harvesting 
countries are Norway and France. Between 120,000 and 130,000 tonnes of Laminaria are 
harvested annually in Norway. The standing stock is estimated to be 10 million tonnes (Vae 
and Ask, 2011). France harvests about 30,000 – 50,000 tonnes annually, mainly Laminaria 
species for hydrocolloid production. The green alga Ulva, is commonly encountered in 
estuaries and inshore coastal areas. When mass proliferation occurs they are known as 
‘green tides.’ They tend to develop at more and more locations along European coasts, due 
to eutrophication, and are used to a small extent as fertilisers but not yet used for industrial 
applications. Nevertheless they may form an interesting source and feedstock for 
carbohydrates (Kraan & Guiry, 2006). 
In Europe, knowledge of seaweed cultivation is scattered across several R&D groups and a 
few industrial groups. The amount of cultivated seaweed is very low, mainly very small 
companies with local facilities for cultivating high value species. Existing industries having 
large scale cultivation are located in Asian countries (China, Philippines, Korea, Indonesia, 
and Japan) and in Chile. The main obstacle in European countries will be labour cost. 
Development of mechanized seaweed cultivation will be required in Europe to achieve cost 
objectives. In Ireland also the aquaculture sector is gradually building know-how and basic 
infrastructure for Laminaria cultivation. Technologies to cultivate Laminaria are well known. 
For instance, the FAO publish a guide to Laminaria culture which is very detailed (Chen, 
2005). The main producers of Laminaria are located in China, Korea and Japan, where 
preservation of natural stocks is not always sustainably managed. The main reason for an 
increased harvest is increased productivity due to selection of the best performing strains, 
improved crop-care, less variability, fertilizing techniques and faster harvesting. This 
strategy will also be required to achieve the low material cost with a high carbohydrate 
content needed for biofuel applications. 
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Brown seaweeds from the Laminariaceae or Fucaceae families have a generative cycle 
including microstages, i.e. zoospores and gametophytes, before fertilization results into new 
sporophytes. Gametophytes are independently living organisms which can be grown and 
propagated vegetatively. The interesting thing is that the gametophytes can be grown in 
biofermentors in a controlled way like microalgae or bacteria. This procedure is used for 
example for production of fucoxanthin from Undaria pinnatifida cultivated under 
microscopic gametophyte form. Because cloning of these gametophyte structures is possible, 
genetically uniform strains can be obtained quickly. These clones can be used also for 
breeding purposes towards varieties of the seaweed in their mature stage. Selection and 
breeding is an essential step to reach a uniform crop and to optimize yield of the targeted 
compounds. Little is known about the composition of these microstages, but based on their 
survival rate in non favorable (a)biotic conditions interesting levels of bioactive 
polysaccharides may be obtained. Cultivation is the most efficient solution to guarantee 
consistent contents in bioactive compounds, whereas seaweeds harvested from wild 
resources undergo uncontrolled composition variations due to changes in growing 
environment. If highly valuables molecules such as fucoidans are aimed as products, 
seaweed aquaculture is therefore a very interesting option. The current cultivation methods 
are still based on Asian techniques although currently programs are initiated in the EU to 
develop open sea based seaweed cultivation technology. Although seaweeds are known for 
their richness in bioactive substances like polysaccharides, proteins, lipids, vitamins and 
polyphenols and have been shown to have a wide range of potential cosmetic, 
pharmaceutical and medical applications, their economic potential is still insufficiently 
developed.  
5.1. Eutrophication and suitable carbohydrate feed stocks 
Inputs of  biodegradable organic matter and inputs deriving from fertilizer run-off together 
with run off or dilution from finfish and shellfish rearing in near-shore waters and land 
based activities have many effects on the quality of coastal inshore waters and are a primary 
cause of eutrophication due to increased availability of nutrients (EPA, 2003). In estuaries 
and shallow coastal bays, this can lead to the proliferation of vast green algal mats, known 
as ‘green tides’(Fletcher 1996). Kelp farms (inshore and near-shore) are able to act as bio-
filters and are able to remove nitrates and phosphates from the surrounding eutrophic 
inshore waters. This allows for increased production of farmed seaweed as demonstrated by 
Chopin et al.,2001, 2008b Eutrophe waters are high in ammonia and phosphorous which can 
be stripped from the water by seaweed at rates varying from 60% up to 90% of the nutrient 
input. Macroalgae are able to take up nitrogen from seawater with rates to allow for a 
biomass increase of ca. 10% day-1. It is well documented that in tank systems the green alga 
Ulva is able to remove 90% of the nitrogenous compounds and the red alga Gracilaria up to 
95% of dissolved ammonium from fish effluent (Neori et al., 2000). By cultivating and 
harvesting macroalgae as biofilters integrated with other shellfish or fish production 
systems, nutrient polution from these aquaculture systems could be alleviated through a 
process called IMTA (Integrated Multitrophic Aquaculture) while increasing production 
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and carrying capacity (Chopin et al.,2001, 2008; Troell et al., 2009). Production of macroalgae 
in near-shore sea cultivation can be harvested for the bioethanol market to produce a value 
added marketable product acting as both an economic incentive and environmental 
incentive.  
5.2. Effect of enrichment on carbohydrates  
High ammonia and nitrate concentrations will alter the proximate composition in the 
macroalgae and cause a shift with higher protein and generally lower carbohydrate levels 
such as starch or dietary fiber as demonstrated by Rosenberg and Ramus, (1982); Pinchetti et 
al., (1998). How exactly it effects the carbohydrate composition is not known but might be 
an interesting way to manipulate carbohydrate content and composition in algae. In the red 
carrageenophyte Kappaphycus alvarezii the effect of ammonium addition in an otherwise 
nitrogen starved environment had a profound impact on the carrageenan content and 
showed increased gel strength of the carrageenan with an increase of ammonia ( Rui et. al., 
1990). 
6. From a hydrocarbon society to carbohydrate society 
Global demand for bio-fuels continues unabated. Rising concerns over environmental 
pollution and global warming, has encouraged the movement to alternate fuels, the world 
ethanol market is projected to reach 100 billion litres this year. Bioethanol is currently 
produced from carbohydrates from and-based crops such as corn and sugar cane. A 
continued use of these crops drives the food versus fuel debate. An alternate feed-stock 
which is abundant and carbohydrate-rich is necessary. The production of such crop needs to 
be sustainable and reduce competition with production of food, feed and industrial crops on 
agricultural inputs (pesticides, fertiliser, land, water). Macroalgae, in specific brown 
seaweeds could meet these challenges, being an abundant and carbon neutral renewable 
resource with potential to reduce green-house gas (GHG) emissions and the man-made 
impact on climate change.  
Macroalgae are fast growing marine plants that can grow to considerable size (up to tens of 
meters in length in the case of Pacific kelp species), although Atlantic species would be 
smaller at ~ 3 m length (Lüning 1990). Growth rates of marine macroalgae far exceed those 
of terrestrial biomass. The large brown algae of kelp forests found on rocky shores inhabit 
an environment of vigorous water movement and turbulent diffusion. This allows very high 
levels of nutrient uptake, photosynthesis and growth. Highest productivity of kelp forests is 
found along the North American Pacific coast, which out-performs that of the most 
productive terrestrial systems (Velimirov et al. 1977). Laminaria-dominated communities of 
the European coasts have an annual productivity of approximately 2 kg carbon per m2, 
which is still higher than, for example, temperate tree plantations or grasslands with a 
productivity of generally less than 1 kg carbon per m2 (Thomas 2002). Production figures 
have been reported in the range of 3.3 – 11.3 kg dry weight m-2 yr-1 for non-cultured and up 
to 13.1 kg dry weight m-2 over 7 month for cultured brown algae compared with 6.1 – 9.5 kg 
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fresh weight m-2  yr-1 for sugar cane, a most productive land plant. In addition marine 
biomass does not require fertilisation as currents and water exchange provide a continuous 
flow of a base level of nitrates and phosphates and large scale cultures may be useful in 
alleviating increased nitrogen levels in inshore waters. Due to the absence of lignin and a 
low content of cellulose, brown macroalgae carbohydrates may be easily convertible in 
biological processes compared to land plants.  
Seaweeds are already farmed on a massive scale in Asia and substantial quantities are also 
harvested from natural populations. Recent research has shown the potential for large scale 
culture of macroalgae in Atlantic waters (Germany; Buck and Buchholz 2004: Canada; 
Chopin et al. 2008: France; Kaas 2006: Ireland; Kraan et al. 2000: Isle of Man, UK; Kain et al. 
1990, Spain; Peteiro et. al., 2006). The challenges now lie in further developing cost-effective 
methodologies to grow, harvest transport and process large quantities of macroalgae.  
A large body of research on fermentation of seaweeds into methane exists starting in the 
early 1980s and is extensively reviewed in Kelly and Dworjanyn (2008).  
The only commercially available biofuels today are first generation biofuels, mainly bioethanol 
and biodiesel, produced from e.g. sugar cane and corn, and rapeseed, respectively. However, 
continued use of these crops will drive the food versus fuels debate even more as demand for 
ethanol increases. Not only does the large-scale production of corn and sugar cane damage the 
environment by the use of pesticides, it uses two other valuable resources: arable land and 
enormous quantities of water. For instance, the production of corn in the USA uses over 3 
trillion litres of water a year in 2007 (Chiu et al. 2009).  
Increased demand and the competition with food production has called for the development 
of second generation biofuels, based on utilization of lignocellulosic biomass, such as wood 
and agricultural waste. Second generation biofuels do not compete with food as a feedstock, 
but they compete for land and fresh water resources. Therefore the challenge is to find a 
feedstock which is abundant and carbohydrate-rich. This crop must be sustainable, use no 
agricultural inputs (pesticides, fertiliser, land, water), and must not be part of the human or 
animal food chain. Such a feedstock and an alternative to terrestrial biomass are marine 
macroalgae or seaweeds. Macroalgae and aquatic biomass are emerging as one of the most 
promising potential sources for biofuels production.  
6.1. Suitable species and production 
Several species of macroalgae accumulate high levels of carbohydrates, which are suitable as 
substrate for microbial conversion processes, e.g. for production of bioethanol, biobutanol as 
biofuels or other desirable chemicals with an attractive high product value. Green algae 
species such as the Ulva sp Linnaeus with high levels of the polysaccharide Ulvan (Lahaye 
and Ray 1996; Lahaye 1998) have been used in ethanol and methane production production 
(Morand et al. 1991, Adams et al. 2009). Brown macroalgae in particular kelp contain 50-60% 
carbohydrates of the dryweight and cultivation techniques have been firmly established for 
the last 50 years. Moreover, kelp is cultivated in large quantities up to 15.5 million wet 
tonnes in the Far East (FAO 2010).  
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Five Atlantic kelp species are suitable for cultivation and have a high carbohydrate level, 
i.e., Saccorhiza polyschides (Lightfoot) Batters; Alaria esculenta (L.) Greville; Laminaria 
hyperborea (Gunnerus) Foslie; Laminaria digitata (Hudson) J.V. Lamouroux; and Saccharina 
latissima (Linnaeus) C.E. Lane, C. Mayes, Druehl & G.W. Saunders (Werner and  Kraan 
2004). They differ in various aspects, such as morphology, ecophysiology and longevity. 
Laminaria digitata and Laminaria hyperborea are the only species that form extended 
monospecific kelp beds.  
The biomass productivity of macroalgae ranges converted to carbon is about 1 to 3.4 kg 
carbon m-2 year-1 (Gao and McKinley 1994; Mann 1982; Mohammed and Fredriksen 2004). 
Seaweed communities of the North Atlantic coasts have an annual productivity of approxi-
mately 2 kg C per m2, which is far higher than, for example, temperate tree plantations or 
grasslands with a productivity of generally less than 1 kg C m-2, year-1 (Mann 1982; 
Chapman 1987; Thomas 2002; Lüning and Pang 2003;  Mohammed and Fredrikson 2004), 
and 2.8 times higher than for sugar cane (Gao and McKinley 1994). Macroalgae can be 
cultivated in the open sea (Zhang et al. 2008; Bartsch et al. 2008; Kelly and Dworjanyn 2008). 
Ocean farming of seaweed does not depend on fresh water and does not occupy land areas 
(Yarish and Pereira 2008). Sustainable utilization of algal biomass - a largely unexplored 
feed stock resource can be a complement to terrestrial biomass for the future global energy 
and carbon security and thereby also strengthen the maritime economies. 
Ocean farming of seaweed has the potential to produce in the order of 40 ton dry weight 
biomass per hectare per annum. An area of 2500 km2, the size of Luxembourg, would be 
able to provide 10 million ton dry biomass, representing 5.6-5.8 million ton carbohydrates. 
With current 90% enzymatic conversion into ethanol (Wargacki et al., 2012) this would yield 
close to 2 billion litres of bioethanol. This is about 2-3 % of the world's global bioethanol pro-
duction (F.O. Licht 2009); however, it would cover about 50% of the EU’s ethanol demand 
(Annon 2008b). The use of algal biomass has the potential to not only replace fossil 
resources, and thereby mitigate climate change, but also aid in the recycling potential of 
nitrates and phosphates in near and inshore waters.  
6.2. Processing and fermentation of macroalgal biomass 
The water content in macroalgae is higher than in terrestrial biomass (80-85 %), making sea-
weeds more suited for microbial conversion than for direct combustion or thermo-chemical 
conversion processes, which is an alternative for land-based biomass (Horn et al. 2000a; 
Ross et al. 2007). Seaweed carbohydrates may be used as substrates for microbial production 
of a wide range of fuels and chemicals. Ethanol production from hexose sugars such as 
glucose, sucrose, laminarin etc. derived from e.g. corn stover or sugar cane, is a well-known 
process. However, hexose-based polysaccharides constitute only about 30-40% of the carbo-
hydrates in kelp. The remaining fraction is composed of C-5 sugars that until now have not 
been applied as substrates for industrial microbial production processes. However, recent 
breakthroughs have been made in C5 sugar fermentation technology allowing up to 90% of 
the available carbohydrates to be fermented (Wargacki, et al., 2012).  
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6.3. Pre-treatment of the seaweed biomass and hydrolysis of the polysaccharides 
of brown seaweed biomass 
Fresh harvested brown seaweed contains about 15-20 % carbohydrates of the total wet 
weight, which equals about 200 g carbohydrates per kg wet weight, which is an appropriate 
substrate concentration for microbial conversion processes (Horn et al. 2000a). Lack of lignin 
in seaweeds implies that the harsh pre-treatment applied for release of fermentable sugars 
from lignocellulosic biomass is not required. Laminaran and mannitol can easily be 
extracted by water (Horn et al. 2000b). Alginates (consisting of polymer blocks of Uronic 
and guluronic acid) is present in the macroalgae biomass at 30-40% (Honya et al. 1993; 
McHugh 2003). Sodium alginate can be removed from the initial extraction solution by 
adding a calcium salt. This causes calcium alginate to form with a fibrous texture; it does 
not dissolve in water and can be separated from it. The separated calcium alginate is 
suspended in water and acid is added to convert it into alginic acid. This fibrous alginic 
acid is easily separated, placed in a planetary type mixer with alcohol, and sodium 
carbonate is gradually added to the paste until all the alginic acid is converted to sodium 
alginate. The paste of sodium alginate is sometimes extruded into pellets that are then 
dried and milled (McHugh 2003) . Due to the high viscosity, dilution with large amounts 
of water is required. The process is operating at alginate concentrations in the order of ~2 
%. Such a dilution cannot be applied to processes aimed at use of alginate as fermentation 
substrate. Preferably, no water should be added, as it will increase the downstream 
processing costs (McHugh 2003).  
Bioethanol production from cellulosic materials can be achieved by running simultaneously 
enzymatic hydrolysis and fermentation. For the wet seaweed biomass it is not as easy due to 
the alginates which are harder to release from the biomass causing enzymatic degradation 
of un-treated biomass and will be rate-limiting step if combined with fermentation. 
Hydrolysis should therefore be a part of the biomass pre-treatment. This hydrolysis can be 
carried out mechanically through grinding and emulsifying equipment, chemically using 
acid or alkali, or enzymatic. Several methods for partial or complete degradation of alginate 
as an integrated part of the mechanical pre-treatment of the biomass are known. Chemical 
hydrolysis should follow existing technologies , e.g. by modification and adaptation of 
methods used for acid and alkali pre-treatment of wood biomass (e.g. Ballesteros 2001; 
Klinke et al. 2001) and by combination of acid- or alkali with steam treatment. Other studies 
with macroalgae demonstrated the need for pre-treatment at 65°C, pH 2 for 1 h prior to 
fermentation (Horn, 2000a; 200b, Percival and McDowell, 1967). This in contrast with 
Adams et al. (2009) who found that these pre-treatments are not required for the 
fermentations with Saccharina latissima conducted, with higher ethanol yields being achieved 
in untreated fermentations than in those with altered pH or temperature pre-reatments. This 
result was seen in fresh and defrosted macroalgae samples using Saccharomyces cerevisiae 
and 1 unit of the enzyme laminarinase per kg of defrosted macroalgae. Nevertheless, the 
easiest and environmental friendliest way of pre-treatment of algal biomass is through a 
combination of mechanical and enzymatic hydrolysis (Doubet and Quatrano 1982).  
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6.4. Ethanol and butanol from brown seaweeds 
Ethanol production from fermentation is the most obvious one as it has a direct application 
in the replacement of fossil fuels. However other products such as butanol and itaconic acid 
can be produced as well which can substitute and/or replace similar products produced 
from fossil resources. There are many microorganisms in the marine environment that can 
degrade and utilize algal carbohydrates as a carbon source for energy. Often these 
microorganisms are associated with the seaweeds being present on the blade surface or in 
tissue as many kelp species produce exo-polysaccharides as mucus layer or shed entire 
skin . This would imply that these organisms possess the necessary enzymes for cleavage 
of the algal polysaccharides. However, compounds such as ethanol and butanol are 
produced by anaerobic fermentation that require the presence of specific metabolic 
pathways generating these compounds as end products, e.g. yeast for ethanol production 
and Clostridia for butanol production. Limited information is available on the efficiency of 
these processes with seaweed carbohydrates (Horn et al. 2000a; 2000b), although several 
brake troughs have recently been made in respect of ethanol production from brown 
seaweeds (Wargacki, et al., 2012).  
6.4.1. Ethanol 
The potential of ethanol production from seaweeds can be calculated and is based on the 
following assumptions: A carbohydrate content of 60 % of dry weight and a 90 % conversion 
ratio to ethanol. Through fermentation one gram of sugar can yield 0.4 g ethanol. This will 
yield 0.22 kg or 0.27 l ethanol from 1 kg dry weight seaweed biomass, corresponding to 
approximately 0.05 l ethanol per kg wet weight.  
Bacteria can be metabolize uronic acids to pyruvate and glyceraldehyde-3-P, which may 
then be fermented to ethanol by the glycolytic pathway (van Maris et al. 2006). In anaerobic 
fermentation processes, as ethanol and butanol production, oxygen is not available for 
removal of excess hydrogen generated. This implies that the conversion reaction from sub-
strate to product must be red-ox balanced. Ethanol-production from hexose sugars is red-ox 
balanced, while production from pentoses or mannitol generates excess hydrogen. In many 
bacteria but not in yeast the enzyme transhydrogenases, solves this problem. Yeasts can 
avoid the problem by receiving a small, controlled supply of oxygen. However, oxygen 
leads to complete oxidation of the substrate to CO2 and water, and reduced ethanol yields. 
Another strategy is introduction of transhydrogenase into strains that lack this, through 
genetic engineering (Fortman et al. 2008; Lee et al. 2008). Prospecting macroalgae (seaweeds) 
as feedstocks for bioconversion into biofuels and commodity chemical compounds is limited 
primarily by the availability of tractable microorganisms that can metabolize alginate 
polysaccharides. Wargacki, et al., (2012) present the discovery of a 36–kilo–base pair DNA 
fragment from Vibrio splendidus encoding enzymes for alginate transport and metabolism. 
The genomic integration of this ensemble, together with an engineered system for 
extracellular alginate depolymerization, generated a microbial platform that can 
simultaneously degrade,uptake, and metabolize alginate. They further engineered for 
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ethanol synthesis, this platform enables bioethanol production directly from macroalgae via 
a consolidated process. 
6.4.2. Butanol  
Butanol is an alternative to ethanol with a higher energy content (butanol 29.2 MJ/l, ethanol 
19.6 MJ/l), compared to gasoline (32 MJ/l). It can be used to supplement both gasoline and 
diesel fuels and can be handled by existing infrastructures (Fortman et al. 2008). Butanol is 
an important industrial chemical and is currently produced via petrochemical processes. In 
the last century butanol was produced through bacterial fermentation of starch rich 
compounds using Clostridia strains (Zverlov et al. 2006), which can use hexose as well as 
pentose sugers. 
7. Outlook 
Macroalgae are an interesting source for a myriad of different bioactive polysaccharides 
ranging from industrial applications to novel food applications. They possess many 
different interesting and often exotic polysaccharides that are currently explored for their 
functional properties in food and biomedicine. However, a far larger application would be 
the use of carbohydrates from cultivated seaweeds for alternative fuel sources. It is the 
exploitation of nature’s energy cycle, photosynthesis and the resulting plant biomass that 
can accelerate this application. Society has to make a transition from a hydrocarbon to a 
carbohydrate economy, with the accrued benefits of carbon neutral biofuel, plastics and 
medecine. Macroalgae are efficient solar energy converters, and can create large amounts of 
biomass in a short-term, however, marine biomass is often an overlooked source, and 
potentially represents a significant source of carbohydrates as a renewable energy source.  
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